Abstract:Background Muscle wasting is a common complication of chronic kidney disease (CKD) that is associated with higher mortality. Although the mechanisms of myofibre loss in CKD has been widely studied, the contribution of muscle precursor cell (MPC) senescence remains poorly understood. Senescent MPCs no longer proliferate and can produce pro-inflammatory factors or cytokines. In this study, we tested the hypothesis that the senescence associated secretory phenotype (SASP) of MPCs contributes to CKD-induced muscle atrophy and weakness. Methods CKD was induced in mice by 5/6th nephrectomy. Kidney function, muscle size, and function were measured, and markers of atrophy, inflammation, and senescence were evaluated using immunohistochemistry, immunoblots, or qPCR. To study the impact of senescence, a senolytics cocktail of dasatinib + quercetin (D&Q) was given orally to mice for 8 weeks. To investigate CKD-induced senescence at the cellular level, primary MPCs were incubated with serum from CKD or control subjects. The roles of specific proteins in MPC senescence were studied using adenoviral transduction, siRNA, and plasmid transfection. Results In the hindlimb muscles of CKD mice, (i) the senescence biomarker SA-beta-gal was sharply increased (similar to 30-fold); (ii) the DNA damage response marker gamma-H2AX was increased 1.9-fold; and (iii) the senescence pathway markers p21 and p16(INK4a) were increased 1.99-fold and 2.82-fold, respectively (all values, P < 0.05), whereas p53 was unchanged. gamma-H2AX, p21, and p16(INK4A) were negatively correlated at P < 0.05 with gastrocnemius weight, suggesting a causal relationship with muscle atrophy. Administration of the senolytics cocktail to CKD mice for 8 weeks eliminated the disease-related elevation of p21, p16(INK4a), and gamma-H2AX, abolished positive SA-beta-gal, and depressed the high levels of the SASP cytokines, TNF-alpha, IL-6, IL-1 beta, and IFN (all values, P < 0.05). Skeletal muscle weight, myofibre cross-sectional area, and grip function were improved in CKD mice receiving D&Q. Markers of protein degradation, inflammation, and MPCs dysfunction were also attenuated by D&Q treatment compared with the vehicle treatment in 5/6th nephrectomy mice (all values, P < 0.05). Uraemic serum induced senescence in cultured MPCs. Overexpression of FoxO1a in MPCs increased the number of p21(+) senescent cells, and p21 siRNA prevented uraemic serum-induced senescence (P < 0.05). Conclusions Senescent MPCs are likely to contribute to the development of muscle wasting during CKD by producing inflammatory cytokines. Limiting senescence with senolytics ameliorated muscle wasting and improved muscle strength in vivo and restored cultured MPC functions. These results suggest potential new therapeutic targets to improve muscle health and function in CKD.

CELLULAR SENESCENCE IMPLICATED IN SEPSIS-INDUCED MUSCLE WEAKNESS AND AMELIORATED WITH METFORMIN

SEPSIS LEADS TO IMPAIRED MITOCHONDRIAL CALCIUM UPTAKE AND SKELETAL MUSCLE WEAKNESS BY REDUCING THE MICU1:MCU PROTEIN RATIO

Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model

A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice.

Proteomic Profiling of Hindlimb Skeletal Muscle Disuse in a Murine Model of Sepsis

Whole milk protein powder separated by low-temperature nanofiltration membrane administration alleviates sepsis-induced myopathy

Cellular senescence and disrupted proteostasis induced by myotube atrophy are prevented with low-dose metformin and leucine cocktail

Impact of prolonged sepsis on neural and muscular components of muscle contractions in a mouse model

Pathophysiology and Treatment Strategies of Acute Myopathy and Muscle Wasting after Sepsis

Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota

The Impact of Senescence on Muscle Wasting in Chronic Kidney Disease.

Roles of programmed death‐1 and muscle innate lymphoid cell‐derived interleukin 13 in sepsis‐induced intensive care unit‐acquired weakness

Melatonin Attenuates Sepsis-Induced Muscle Atrophy by Regulating the PI3K/Akt Signaling Pathway

17β-estradiol attenuates sepsis-induced myopathy in mice

Early exercise and attenuation of myopathy in the patient with sepsis in ICU

Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis

Sepsis-induced myopathy.

Sepsis-Associated Muscle Wasting: A Comprehensive Review from Bench to Bedside

Astragaloside IV Alleviates Sepsis-Induced Muscle Atrophy by Inhibiting the TGF-β1/Smad Signaling Pathway.

Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice